These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

316 related items for PubMed ID: 6997229

  • 21. Inhibition of Proteus vulgaris urease by hydroxamic acids.
    Hase J, Kobashi K.
    J Biochem; 1967 Sep; 62(3):293-9. PubMed ID: 5586497
    [No Abstract] [Full Text] [Related]

  • 22. Inhibition of urease activity by dipeptidyl hydroxamic acids.
    Odake S, Nakahashi K, Morikawa T, Takebe S, Kobashi K.
    Chem Pharm Bull (Tokyo); 1992 Oct; 40(10):2764-8. PubMed ID: 1464106
    [Abstract] [Full Text] [Related]

  • 23. Computer-aided optimization of phosphinic inhibitors of bacterial ureases.
    Vassiliou S, Kosikowska P, Grabowiecka A, Yiotakis A, Kafarski P, Berlicki L.
    J Med Chem; 2010 Aug 12; 53(15):5597-606. PubMed ID: 20684601
    [Abstract] [Full Text] [Related]

  • 24. Proteus morgani is less frequently associated with urinary tract infections than Proteus mirabilis--an explanation.
    Senior BW.
    J Med Microbiol; 1983 Aug 12; 16(3):317-22. PubMed ID: 6348289
    [Abstract] [Full Text] [Related]

  • 25. Acetohydroxamic acid: clinical studies of a urease inhibitor in patients with staghorn renal calculi.
    Griffith DP, Gibson JR, Clinton CW, Musher DM.
    J Urol; 1978 Jan 12; 119(1):9-15. PubMed ID: 23442
    [Abstract] [Full Text] [Related]

  • 26. Morphological changes in Proteus mirabilis O18 biofilm under the influence of a urease inhibitor and a homoserine lactone derivative.
    Czerwonka G, Arabski M, Wąsik S, Jabłońska-Wawrzycka A, Rogala P, Kaca W.
    Arch Microbiol; 2014 Mar 12; 196(3):169-77. PubMed ID: 24481535
    [Abstract] [Full Text] [Related]

  • 27. Therapy for urolithiasis with hydroxamic acids. IV. Prevention of infected urinary stone formation with N-(pivaloyl)glycinohydroxamic acid.
    Satoh M, Munakata K, Kitoh K, Seto N, Kanazawa T, Takeuchi H, Yoshida O.
    J Pharmacobiodyn; 1981 Jul 12; 4(7):469-74. PubMed ID: 7028944
    [Abstract] [Full Text] [Related]

  • 28. Urease-positive bacteriuria and obstruction of long-term urinary catheters.
    Mobley HL, Warren JW.
    J Clin Microbiol; 1987 Nov 12; 25(11):2216-7. PubMed ID: 3320089
    [Abstract] [Full Text] [Related]

  • 29. Partial dissolution of struvite calculus with oral acetohydroxamic acid.
    Rodman JS, Williams JJ, Peterson CM.
    Urology; 1983 Oct 12; 22(4):410-2. PubMed ID: 6356559
    [Abstract] [Full Text] [Related]

  • 30. Prevention of infected urinary stones in rats by urease inhibitor: a new hydroxamic acid derivative.
    Takeuchi H, Kobashi K, Yoshida O.
    Invest Urol; 1980 Sep 12; 18(2):102-5. PubMed ID: 6997228
    [Abstract] [Full Text] [Related]

  • 31. Inhibitors of bacterial urease: microbiological considerations on hydroxyurea influenza virus.
    Perrone G, Ferrari C, Arghittu M.
    Boll Ist Sieroter Milan; 1982 Sep 12; 61(6):513-5. PubMed ID: 6765400
    [Abstract] [Full Text] [Related]

  • 32. Effect of acetohydroxamic acid on rumen urease activity in vitro.
    Makkar HP, Sharma OP, Dawra RK, Negi SS.
    J Dairy Sci; 1981 Apr 12; 64(4):643-8. PubMed ID: 7264024
    [Abstract] [Full Text] [Related]

  • 33. Design, synthesis, and evaluation of novel organophosphorus inhibitors of bacterial ureases.
    Vassiliou S, Grabowiecka A, Kosikowska P, Yiotakis A, Kafarski P, Berlicki Ł.
    J Med Chem; 2008 Sep 25; 51(18):5736-44. PubMed ID: 18717581
    [Abstract] [Full Text] [Related]

  • 34. Inhibition of crystallization caused by Proteus mirabilis during the development of infectious urolithiasis by various phenolic substances.
    Torzewska A, Rozalski A.
    Microbiol Res; 2014 Sep 25; 169(7-8):579-84. PubMed ID: 24239192
    [Abstract] [Full Text] [Related]

  • 35. Urease production by Helicobacter (Campylobacter) pylori.
    Vogt K, Hahn H.
    Zentralbl Bakteriol; 1991 Apr 25; 275(1):63-72. PubMed ID: 1930566
    [Abstract] [Full Text] [Related]

  • 36. Further observations on the potentiation of the antibacterial effect of methenamine by acetohydroxamic acid.
    Musher DM, Griffith DP, Templeton GB.
    J Infect Dis; 1976 May 25; 133(5):564-7. PubMed ID: 4573
    [Abstract] [Full Text] [Related]

  • 37. Mechanisms of regulation of urease biosynthesis in Proteus rettgeri.
    Magaña-Plaza I, Ruiz-Herrera J.
    J Bacteriol; 1967 Apr 25; 93(4):1294-301. PubMed ID: 6032508
    [Abstract] [Full Text] [Related]

  • 38. Therapy for urolithiasis by hydroxamic acids. III. Urease inhibitory potency and urinary excretion rate of N-acylglycinohydroxamic acids.
    Munakata K, Kobashi K, Takebe S, Hase J.
    J Pharmacobiodyn; 1980 Sep 25; 3(9):451-6. PubMed ID: 7007614
    [Abstract] [Full Text] [Related]

  • 39. The enthalpimetric determination of inhibition constants for the inhibition of urease by acetohydroxamic acid.
    Zaborska W, Leszko M, Kot M, Juszkiewicz A.
    Acta Biochim Pol; 1997 Sep 25; 44(1):89-98. PubMed ID: 9241359
    [Abstract] [Full Text] [Related]

  • 40. Regulation by repression of urease biosynthesis in Proteus rettgeri.
    Zorn C, Dietrich R, Kaltwasser H.
    Z Allg Mikrobiol; 1982 Sep 25; 22(3):197-203. PubMed ID: 6126049
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.